Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 16

    1.

    Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.

    Okulicz JF, Marconi VC, Landrum ML, Wegner S, Weintrob A, Ganesan A, Hale B, Crum-Cianflone N, Delmar J, Barthel V, Quinnan G, Agan BK, Dolan MJ; Infectious Disease Clinical Research Program (IDCRP) HIV Working Group.

    J Infect Dis. 2009 Dec 1;200(11):1714-23.PMID: 19852669 [PubMed - in process]Related articles

    2.

    A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.

    Wang D, Larder B, Revell A, Montaner J, Harrigan R, De Wolf F, Lange J, Wegner S, Ruiz L, Pérez-Elías MJ, Emery S, Gatell J, D'Arminio Monforte A, Torti C, Zazzi M, Lane C.

    Artif Intell Med. 2009 Sep;47(1):63-74. Epub 2009 Jun 12.PMID: 19524413 [PubMed - indexed for MEDLINE]Related articles

    3.

    The impact of nelfinavir exposure on cancer development among a large cohort of HIV-infected patients.

    Crum-Cianflone NF, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, Barthel RV, Fraser S, Roediger MP, Agan B, Wegner S.

    J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):305-9.PMID: 19412116 [PubMed - indexed for MEDLINE]Related articles

    4.

    Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007.

    Crum-Cianflone N, Eberly L, Zhang Y, Ganesan A, Weintrob A, Marconi V, Barthel RV, Fraser S, Agan BK, Wegner S.

    Clin Infect Dis. 2009 May 1;48(9):1285-92.PMID: 19309306 [PubMed - indexed for MEDLINE]Related articles

    5.

    Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.

    Crum-Cianflone N, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, Barthel RV, Fraser S, Agan BK, Wegner S.

    AIDS. 2009 Jan 2;23(1):41-50.PMID: 19050385 [PubMed - indexed for MEDLINE]Related articles

    6.

    Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART.

    Weintrob AC, Fieberg AM, Agan BK, Ganesan A, Crum-Cianflone NF, Marconi VC, Roediger M, Fraser SL, Wegner SA, Wortmann GW.

    J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):40-7.PMID: 18667932 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters.

    Shiels MS, Cole SR, Wegner S, Armenian H, Chmiel JS, Ganesan A, Marconi VC, Martinez-Maza O, Martinson J, Weintrob A, Jacobson LP, Crum-Cianflone NF.

    J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):485-90.PMID: 18614916 [PubMed - indexed for MEDLINE]Related articles

    8.

    The development of artificial neural networks to predict virological response to combination HIV therapy.

    Larder B, Wang D, Revell A, Montaner J, Harrigan R, De Wolf F, Lange J, Wegner S, Ruiz L, Pérez-Elías MJ, Emery S, Gatell J, Monforte AD, Torti C, Zazzi M, Lane C.

    Antivir Ther. 2007;12(1):15-24.PMID: 17503743 [PubMed - indexed for MEDLINE]Related articles

    9.

    Race and mental health diagnosis are risk factors for highly active antiretroviral therapy failure in a military cohort despite equal access to care.

    Hartzell JD, Spooner K, Howard R, Wegner S, Wortmann G.

    J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):411-6.PMID: 17195762 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effectiveness of highly-active antiretroviral therapy by race/ethnicity.

    Silverberg MJ, Wegner SA, Milazzo MJ, McKaig RG, Williams CF, Agan BK, Armstrong AW, Gange SJ, Hawkes C, O'Connell RJ, Ahuja SK, Dolan MJ; Tri-Service AIDS Clinical Consortium Natural History Study Group.

    AIDS. 2006 Jul 13;20(11):1531-8.PMID: 16847408 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

    Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR; Triservice AIDS Clinical Consortium.

    J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):194-200.PMID: 16394852 [PubMed - indexed for MEDLINE]Related articles

    12.

    Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

    Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF.

    Cancer. 2005 Oct 1;104(7):1505-11.PMID: 16104038 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Lost in translation: implications of HIV-1 codon usage for immune escape and drug resistance.

    Kijak GH, Currier JR, Tovanabutra S, Cox JH, Michael NL, Wegner SA, Birx DL, McCutchan FE.

    AIDS Rev. 2004 Jan-Mar;6(1):54-60. Review.PMID: 15168741 [PubMed - indexed for MEDLINE]Related articles

    14.

    Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial.

    Wegner SA, Wallace MR, Aronson NE, Tasker SA, Blazes DL, Tamminga C, Fraser S, Dolan MJ, Stephan KT, Michael NL, Jagodzinski LL, Vahey MT, Gilcrest JL, Tracy L, Milazzo MJ, Murphy DJ, McKenna P, Hertogs K, Rinehart A, Larder B, Birx DL; RV-125 Centers for Education and Research on Therapeutics Study Team.

    Clin Infect Dis. 2004 Mar 1;38(5):723-30. Epub 2004 Feb 6.PMID: 14986258 [PubMed - indexed for MEDLINE]Related articles

    15.

    Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort.

    Brodine SK, Starkey MJ, Shaffer RA, Ito SI, Tasker SA, Barile AJ, Tamminga CL, Stephan KT, Aronson NE, Fraser SL, Wallace MR, Wegner SA, Mascola JR, McCutchan FE.

    AIDS. 2003 Nov 21;17(17):2521-7.PMID: 14600525 [PubMed - indexed for MEDLINE]Related articles

    16.

    Correlates of human herpesvirus-8 seropositivity among U.S. military members recently infected with human immunodeficiency virus.

    Crum NF, Wallace MR, Stephan K, Blazes DL, Aronson N, Tasker SA, Thomas AG, Wegner S, Casper C, Wald A, Corey L, Brodine SK.

    Sex Transm Dis. 2003 Sep;30(9):713-8.PMID: 12972795 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...